INVESTOR DEADLINE NOTICE : The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Inovio Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm
Investors who purchased the Company’s securities between February 14, 2020 and March 9, 2020, inclusive (the ”Class Period”), are encouraged to contact the firm before May 11, 2020.
www.schallfirm.com, or by email at email@example.com.” data-reactid=”31″>We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at firstname.lastname@example.org.
The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.
According to the Complaint, the Company made false and misleading statements to the market. Inovio made misleading statements about its purported development of a vaccine for COVID-19 coronavirus. The materially misleading statements artificially inflated the Company’s share price, resulting in investor losses. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Inovio, investors suffered damages,Brian Schall, Esq.
www.schallfirm.com‘ data-reactid=”38″>The Schall Law Firm
Brian Schall, Esq.
Source : ACCESSWIRE Link